BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 16107215)

  • 21. High resolution computed tomography in early scleroderma lung disease.
    Warrick JH; Bhalla M; Schabel SI; Silver RM
    J Rheumatol; 1991 Oct; 18(10):1520-8. PubMed ID: 1765976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome.
    Bouros D; Wells AU; Nicholson AG; Colby TV; Polychronopoulos V; Pantelidis P; Haslam PL; Vassilakis DA; Black CM; du Bois RM
    Am J Respir Crit Care Med; 2002 Jun; 165(12):1581-6. PubMed ID: 12070056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomarkers from bronchoalveolar lavage fluid in systemic sclerosis patients with interstitial lung disease relate to severity of lung fibrosis.
    Hesselstrand R; Wildt M; Bozovic G; Andersson-Sjöland A; Andréasson K; Scheja A; Westergren-Thorsson G; Bjermer L; Wuttge DM
    Respir Med; 2013 Jul; 107(7):1079-86. PubMed ID: 23660398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis.
    Prasse A; Pechkovsky DV; Toews GB; Schäfer M; Eggeling S; Ludwig C; Germann M; Kollert F; Zissel G; Müller-Quernheim J
    Arthritis Rheum; 2007 May; 56(5):1685-93. PubMed ID: 17469163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistence of abnormal bronchoalveolar lavage findings after cyclophosphamide treatment in scleroderma patients with interstitial lung disease.
    Mittoo S; Wigley FM; Wise R; Xiao H; Hummers L
    Arthritis Rheum; 2007 Dec; 56(12):4195-202. PubMed ID: 18050251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessments of pulmonary involvement in patients with systemic sclerosis.
    Gohari Moghadam K; Gharibdoost F; Parastandechehr G; Salehian P
    Arch Iran Med; 2011 Jan; 14(1):22-6. PubMed ID: 21194257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary fibrosis in systemic sclerosis: association with myocardial fibrosis.
    Nicholson PJ; Hegarty C; Jackson M; Keane D; Fitzgerald O; Bresnihan B; Veale D; Dodd JD
    J Thorac Imaging; 2012 Jan; 27(1):44-50. PubMed ID: 21107283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrasound signs of pulmonary fibrosis in systemic sclerosis as timely indicators for chest computed tomography.
    Sperandeo M; De Cata A; Molinaro F; Trovato FM; Catalano D; Simeone A; Varriale A; Martines GF; Trovato G
    Scand J Rheumatol; 2015; 44(5):389-98. PubMed ID: 26099251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive investigation of novel serum markers of pulmonary fibrosis associated with systemic sclerosis and dermato/polymyositis.
    Kumánovics G; Minier T; Radics J; Pálinkás L; Berki T; Czirják L
    Clin Exp Rheumatol; 2008; 26(3):414-20. PubMed ID: 18578962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between cutaneous and pulmonary involvement in systemic sclerosis.
    Morelli S; Barbieri C; Sgreccia A; Ferrante L; Pittoni V; Conti F; Gualdi G; Polettini E; Carlesimo OA; Calvieri S
    J Rheumatol; 1997 Jan; 24(1):81-5. PubMed ID: 9002015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring.
    Savarino E; Bazzica M; Zentilin P; Pohl D; Parodi A; Cittadini G; Negrini S; Indiveri F; Tutuian R; Savarino V; Ghio M
    Am J Respir Crit Care Med; 2009 Mar; 179(5):408-13. PubMed ID: 19096004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HRCT and scleroderma: semiquantitative evaluation of lung damage and functional abnormalities.
    Bellia M; Cannizzaro F; Scichilone N; Riili M; Triolo G; Midiri M; Lagalla R
    Radiol Med; 2009 Mar; 114(2):190-203. PubMed ID: 19266260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [High-resolution computer tomography in the diagnosis of cryptogenic fibrosing alveolitis. Correlation with pulmonary function and bronchoalveolar lavage].
    Polák J; Homolka J; Vasáková M; Svobodová L; Gorcíková E
    Cas Lek Cesk; 1996 Jul; 135(13):417-22. PubMed ID: 8925539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
    Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
    Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A longitudinal study of pulmonary involvement in primary Sjögren's syndrome: relationship between alveolitis and subsequent lung changes on high-resolution computed tomography.
    Salaffi F; Manganelli P; Carotti M; Baldelli S; Blasetti P; Subiaco S; Binci MC; Bichi Secchi E; Amici F; Cervini C
    Br J Rheumatol; 1998 Mar; 37(3):263-9. PubMed ID: 9566665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Correlation between bronchoalveolar lavage and lung function in patients with systemic sclerosis and rheumatoid arthritis].
    Pejcić T; Stanković I; Rancić M; Djordjević I; Ristić L; Vojinović J
    Srp Arh Celok Lek; 2005 Dec; 133 Suppl 2():129-33. PubMed ID: 16535997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-invasive diagnostic and functional evaluation of cardiac and pulmonary involvement in systemic sclerosis.
    Sergiacomi G; De Nardo D; Capria A; Manenti G; Fabiano S; Borzi M; De Sanctis G; Konda D; Sperandio M; Schillaci O; Masala S; Simonetti G; Fontana L
    In Vivo; 2004; 18(2):229-35. PubMed ID: 15113051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Symptoms from the internal organs of patients with systemic sclerosis in the light of selected diagnostic tests].
    Sierakowska M; Sierakowski S; Doroszkiewicz H; Lewko J; Jankowiak B; Kowalczuk K; Van Damme-Ostapowicz K; Krajewska-Kułak E
    Pol Merkur Lekarski; 2011 Feb; 30(176):116-20. PubMed ID: 21544981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis.
    Meloni F; Caporali R; Marone Bianco A; Paschetto E; Morosini M; Fietta AM; Patrizio V; Bobbio-Pallavicini F; Pozzi E; Montecucco C
    Sarcoidosis Vasc Diffuse Lung Dis; 2004 Jun; 21(2):111-8. PubMed ID: 15281432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nailfold capillary microscopy can suggest pulmonary disease activity in systemic sclerosis.
    Bredemeier M; Xavier RM; Capobianco KG; Restelli VG; Rohde LE; Pinotti AF; Pitrez EH; Vieira MV; Fontoura MA; Ludwig DH; Brenol JC
    J Rheumatol; 2004 Feb; 31(2):286-94. PubMed ID: 14760798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.